Inventor · disambiguated record
Naozumi Harada
Also filed as: HARADA NAOZUMI
4 granted patents·7 pending applications·1 citations·filing 2007–2024
57Inventor score
Files withUNIV MIE5UNITED IMMUNITY CO LTD3GENERAL INCORPORATED ASS PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION1NAGURA KENJI1SHIKU HIROSHI1
Top patents by PatentIndex Score
11 records- 0168US11083744B2Therapeutic agent associated with suppression of proliferation and metastasis of tumor, which comprises exosomes released from cytotoxic T cells and targets cancer stromal/mesenchymal cellsUNIV MIE·Filed 2016·Granted Aug 10, 2021·1 cites·13 claims
- 0267US2022062398A1Long chain antigen containing interepitope sequence that promotes antigen presentation to t cellsUNIV MIE·Filed 2021·Application pending·0 cites
- 0366US11179450B2Long chain antigen containing interepitope sequence that promotes antigen presentation to T cellsUNIV MIE·Filed 2018·Granted Nov 23, 2021·0 cites·23 claims
- 0458US2025255974A1ComplexUNITED IMMUNITY CO LTD·Filed 2024·Application pending·0 cites
- 0554US12059471B2ComplexUNITED IMMUNITY CO LTD·Filed 2021·Granted Aug 13, 2024·0 cites·10 claims
- 0654US2016367651A1T cell inducing vaccine containing an interepitope sequence that promotes antigen presentationUNIV MIE·Filed 2014·Application pending·0 cites
- 0750US2024342107A1Cancer therapeutic agentUNITED IMMUNITY CO LTD·Filed 2022·Application pending·0 cites
- 0849US11213538B2Agent for overcoming immunosuppression and use thereofGENERAL INCORPORATED ASS PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION·Filed 2017·Granted Jan 4, 2022·0 cites·4 claims
- 0947US2019111078A1Pretreatment drug for t cell infusion therapy for immune-checkpoint inhibitor-resistant tumorUNIV MIE·Filed 2017·Application pending·0 cites
- 1046US2012029175A1Protein Complex and Process for Producing the SameNAGURA KENJI·Filed 2007·Application pending·0 cites
- 1138US2014322344A1Vaccine preparation for cancer treatmentSHIKU HIROSHI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naozumi Harada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →